Skip to main content

Main menu

  • Home
  • Current issue
  • Past issues
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • ERS author centre
    • COVID-19 submission information
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • Past issues
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • ERS author centre
    • COVID-19 submission information
  • Alerts
  • Subscriptions

The challenge of targeting EGFR: experience with gefitinib in nonsmall cell lung cancer

A.A. Armour, C.L. Watkins
European Respiratory Review 2010 19: 186-196; DOI: 10.1183/09059180.00005110
A.A. Armour
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: Alison.Armour@astrazeneca.com
C.L. Watkins
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 19 no. 117 186-196
DOI 
https://doi.org/10.1183/09059180.00005110
PubMed 
20956191

Published By 
European Respiratory Society
Print ISSN 
0905-9180
Online ISSN 
1600-0617
History 
  • Received May 21, 2010
  • Accepted June 29, 2010
  • Published online August 31, 2010.

Copyright & Usage 
©ERS 2010

Author Information

  1. A.A. Armour and
  2. C.L. Watkins
  1. AstraZeneca, Macclesfield, UK.
  1. A.A. Armour, AstraZeneca, Alderley Park, Macclesfield, Cheshire, SK10 4TG, UK. E-mail: Alison.Armour{at}astrazeneca.com
View Full Text

Article usage

Article usage: August 2010 to March 2021

AbstractFullPdf
Aug 20101414
Sep 20101188398378
Oct 2010626114131
Nov 201052859101
Dec 20101904448
Jan 20111763655
Feb 20112144962
Mar 20111703955
Apr 20111386161
May 2011855931
Jun 20111035053
Jul 2011715451
Aug 2011964446
Sep 2011803517
Oct 2011873825
Nov 2011999244
Dec 2011984247
Jan 2012653726
Feb 2012876346
Mar 2012596936
Apr 2012679435
May 20121059737
Jun 2012705839
Jul 2012624737
Aug 2012645730
Sep 2012683641
Oct 2012687447
Nov 2012587458
Dec 2012786726
Jan 201313111557
Feb 2013406540
Mar 2013576335
Apr 2013704330
May 2013985546
Jun 2013383824
Jul 2013193922
Aug 2013133712
Sep 2013283327
Oct 2013253318
Nov 2013212723
Dec 2013313124
Jan 2014161917
Feb 2014332111
Mar 2014273329
Apr 2014285444
May 2014254429
Jun 2014112812
Jul 2014183919
Aug 201482815
Sep 2014263523
Oct 2014343942
Nov 2014202625
Dec 2014143622
Jan 2015163325
Feb 2015163215
Mar 2015225425
Apr 2015239760
May 2015354118
Jun 2015124014
Jul 2015303724
Aug 2015252923
Sep 2015164821
Oct 201543926
Nov 2015610519
Dec 201524918
Jan 2016116966
Feb 201646321
Mar 20162011958
Apr 2016812732
May 2016812214
Jun 2016410626
Jul 201658423
Aug 20161010415
Sep 2016139731
Oct 20161510937
Nov 20161119627
Dec 20162012527
Jan 2017712121
Feb 2017512018
Mar 2017714217
Apr 20175886
May 2017710513
Jun 20174845
Jul 201768814
Aug 201729410
Sep 2017311524
Oct 201751049
Nov 2017510413
Dec 201729513
Jan 201814818
Feb 2018233510
Mar 2018034310
Apr 201802009
May 2018025217
Jun 201802238
Jul 201801919
Aug 2018014014
Sep 2018113815
Oct 2018129912
Nov 2018050621
Dec 2018130221
Jan 2019219333
Feb 2019223025
Mar 2019233324
Apr 2019130335
May 2019429423
Jun 2019021419
Jul 2019129418
Aug 2019642615
Sep 2019343021
Oct 2019242629
Nov 2019038322
Dec 2019327622
Jan 2020416622
Feb 2020123326
Mar 2020015632
Apr 2020017642
May 2020718229
Jun 2020313723
Jul 2020311930
Aug 2020610320
Sep 2020413627
Oct 20201220444
Nov 2020223744
Dec 2020419624
Jan 2021517735
Feb 2021621732
Mar 2021420054

Altmetrics

PreviousNext
Back to top
View this article with LENS
Vol 19 Issue 117 Table of Contents
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The challenge of targeting EGFR: experience with gefitinib in nonsmall cell lung cancer
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Alerts
Sign In to Email Alerts with your Email Address
Citation Tools
The challenge of targeting EGFR: experience with gefitinib in nonsmall cell lung cancer
A.A. Armour, C.L. Watkins
European Respiratory Review Sep 2010, 19 (117) 186-196; DOI: 10.1183/09059180.00005110

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
The challenge of targeting EGFR: experience with gefitinib in nonsmall cell lung cancer
A.A. Armour, C.L. Watkins
European Respiratory Review Sep 2010, 19 (117) 186-196; DOI: 10.1183/09059180.00005110
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • TARGETING THE EGFR WITH GEFITINIB
    • DETERMINING THE OPTIMUM BIOLOGICAL DOSE
    • IDENTIFYING POTENTIAL PREDICTORS OF RESPONSE TO GEFITINIB
    • THE GEFITINIB MONOTHERAPY EXPERIENCE: FROM AN UNSELECTED PRETREATED POPULATION TO FIRST-LINE USE IN PATIENTS WITH EGFR MUTATION-POSITIVE NSCLC
    • LESSONS LEARNED
    • SUMMARY
    • Acknowledgments
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Subjects

  • Lung cancer
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • AATD and chronic respiratory disorders
  • Subglottic secretion drainage for preventing ventilator-associated pneumonia
  • Current and future applications of liquid biopsy in NSCLC
Show more Review

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERR

  • Journal information
  • Editorial board
  • Reviewers
  • Press
  • Permissions and reprints
  • Advertising
  • Sponsorship

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Submit a manuscript
  • ERS author centre

For readers

  • Alerts
  • Subjects
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN: 0905-9180
Online ISSN: 1600-0617

Copyright © 2021 by the European Respiratory Society